


Searching News Database: Traversa Therapeutics
HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
HSMN NewsFeed - 4 Feb 2008
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
